Treatment non-response in OCD: methodological issues and operational definitions.
While controlled trials with SRIs have demonstrated a selective efficacy in obsessive-compulsive disorder (OCD), up to 40-60% of patients do not have a satisfactory outcome. Non-response to treatment in OCD is associated with serious social disability. There are a large number of non-responsive patients, and they are difficult to cluster due to ambiguities in the diagnostic criteria, possibility of subtypes, and a high rate of comorbidity. Moreover, the findings of current studies of so-called 'non-responsive' cases are currently non-generalizable because of the lack of an operational definition of non-response. The result has been that a cumulative body of data on a reasonably homogeneous sample of non-responders has not been developed. The aims of this paper are to clarify some of the obstacles in defining stages of response and levels of non-response and, through a comprehensive analysis, to propose a systematic nosology for this rather common condition. Better characterization of which patients respond and do not respond to various treatments will enable more accurate clustering of patients, and help facilitate multi-site data collection for future research trials.
Mount Sinai School of Medicine, New York, NY, USA. s.pallanti@agora.stm.it
Stefano
S
Pallanti
Eric
E
Hollander
Carol
C
Bienstock
Lorrin
L
Koran
James
J
Leckman
Donatella
D
Marazziti
Michele
M
Pato
Dan
D
Stein
Joseph
J
Zohar
D004351:Drug Resistance; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors